MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New transplant combo aims to tame Graft-Versus-Host disease
Disease control OngoingThis study tests a stem cell transplant method for people with blood cancers like leukemia or lymphoma. The approach combines chemotherapy and radiation before transplant with a drug called cyclophosphamide after transplant to lower the risk of graft-versus-host disease, where do…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
New combo before transplant aims to beat High-Risk leukemia
Disease control TerminatedThis study is for people with high-risk acute leukemia or myelodysplastic syndrome (MDS). It tests a new, stronger conditioning regimen—combining targeted radiation (TMLI) with two chemotherapy drugs—given before a donor stem cell transplant. The goal is to find the safest dose t…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC